Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06029309 · ClinicalTrials.gov registry record · Phase 1

Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma

A Phase 1 study of Mantle Cell Lymphoma, sponsored by Alvaro Alencar, MD.

Recruiting
Registry status
Phase 1
Development phase
27
Enrollment target
1
Study location

NCT06029309 is a Phase 1 study of Mantle Cell Lymphoma that is actively recruiting participants, run by Alvaro Alencar, MD. The registered enrollment target is 27 participants, below the 104-participant average among 102 other Mantle Cell Lymphoma trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06029309, a Phase 1 study of Mantle Cell Lymphoma, is actively recruiting participants, sponsored by Alvaro Alencar, MD.

RECRUITING
Registry status
Phase 1
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma. Another purpose is to assess how well the combination treatment works in patients with the study disease.

Conditions Studied

Mantle Cell Lymphoma

Interventions

  • DRUG Zanubrutinib
  • DRUG Tafasitamab

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2024-05-03
Est. Completion 2032-05-01
Phase Phase 1

Sponsor

Alvaro Alencar, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06029309

The ClinicalTrials.gov registry entry for NCT06029309 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 102 other Mantle Cell Lymphoma trials with a reported enrollment target (74% lower). The listed sponsor is Alvaro Alencar, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mantle Cell Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Zanubrutinib is the first listed.

NCT06029309 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06029309 about?

NCT06029309 is a clinical study titled "Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma". The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma. Another purpose is to assess how well the combination treatment works in patients with the study disease.

What is the current status of trial NCT06029309?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2024-05-03. Estimated completion is 2032-05-01.

What conditions does trial NCT06029309 study?

This clinical trial studies the following conditions: Mantle Cell Lymphoma.

What interventions are being tested in trial NCT06029309?

The interventions under investigation include: Zanubrutinib (DRUG), Tafasitamab (DRUG).

Who is sponsoring clinical trial NCT06029309?

This trial is sponsored by Alvaro Alencar, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06029309 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mantle Cell Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mantle Cell Lymphoma

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.